VelaLabs Announces Strategic Partnership with EarlyHealth Group to Support Biological Drugs Development
VelaLabs GmbH, a leading provider of analytical and quality services for biopharmaceutical development, has signed a Memorandum of Understanding (MoU) with EarlyHealth Group to establish comprehensive solutions for the development of advanced biological drugs. The partnership brings together the strengths Mehr